Funds holding CURANEX PHARMACEUTICALS INC
ISIN US23126K1060 · United States
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 8.4K $
- Share of capital
- 0.1 % of 31.4M shares on Aug 14, 2026
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 18,670 | 8.4K $ | 0.06 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 18,670 | 0.0 % |
| 2026Q1 | 1 | 18,670 |
Institutional managers
8 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 111,130 | 56.8K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 56,651 | 29K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 51,289 | 26.2K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 50,559 | 25.9K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 20,254 | 10.4K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 19,332 | 9.9K $ | as of Mar 31, 2026 |
| Jump Financial, LLC | 10,551 | 5.4K $ | as of Mar 31, 2026 |
| UBS Group AG | 7,995 | 4.1K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding CURANEX PHARMACEUTICALS INC". https://titelia.com/en/stocks/curanex-pharmaceuticals-inc-US23126K1060